Letter to the Editor Regarding: Safety of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies Article Swipe

PDF

Jonathan Douxfils , Emma Boretti , Charlotte Beaudart , Jean-Michel Dogné ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1007/s12325-025-03242-3

Related Topics

Medicine

Menopause

Internal Medicine

Randomized Controlled Trial

Physical Therapy

Concepts

Medicine Vasomotor Menopause Rheumatology Internal medicine Randomized controlled trial Physical therapy Intensive care medicine

Metadata

Type: letter
Language: en
Landing Page: https://doi.org/10.1007/s12325-025-03242-3
PDF: https://link.springer.com/content/pdf/10.1007/s12325-025-03242-3.pdf
OA Status: hybrid
References: 8
Related Works: 10
OpenAlex ID: https://openalex.org/W4411041642

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4411041642

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1007/s12325-025-03242-3

Digital Object Identifier
Title: Letter to the Editor Regarding: Safety of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies

Work title
Type: letter

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-06-04

Full publication date if available
Authors: Jonathan Douxfils, Emma Boretti, Charlotte Beaudart, Jean-Michel Dogné

List of authors in order
Landing page: https://doi.org/10.1007/s12325-025-03242-3

Publisher landing page
PDF URL: https://link.springer.com/content/pdf/10.1007/s12325-025-03242-3.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: hybrid

Open access status per OpenAlex
OA URL: https://link.springer.com/content/pdf/10.1007/s12325-025-03242-3.pdf

Direct OA link when available
Concepts: Medicine, Vasomotor, Menopause, Rheumatology, Internal medicine, Randomized controlled trial, Physical therapy, Intensive care medicine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
References (count): 8

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4411041642
doi	https://doi.org/10.1007/s12325-025-03242-3
ids.doi	https://doi.org/10.1007/s12325-025-03242-3
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/40465198
ids.openalex	https://openalex.org/W4411041642
fwci
type	letter
title	Letter to the Editor Regarding: Safety of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies
biblio.issue	8
biblio.volume	42
biblio.last_page	4091
biblio.first_page	4089
topics[0].id	https://openalex.org/T10756
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9991000294685364
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1311
topics[0].subfield.display_name	Genetics
topics[0].display_name	Estrogen and related hormone effects
topics[1].id	https://openalex.org/T10694
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.998199999332428
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2712
topics[1].subfield.display_name	Endocrinology, Diabetes and Metabolism
topics[1].display_name	Menopause: Health Impacts and Treatments
topics[2].id	https://openalex.org/T11146
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9980999827384949
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2712
topics[2].subfield.display_name	Endocrinology, Diabetes and Metabolism
topics[2].display_name	Hormonal and reproductive studies
is_xpac	False
apc_list.value	3390
apc_list.currency	EUR
apc_list.value_usd	4390
apc_paid.value	3390
apc_paid.currency	EUR
apc_paid.value_usd	4390
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.9363179206848145
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C2776214587
concepts[1].level	2
concepts[1].score	0.8678548336029053
concepts[1].wikidata	https://www.wikidata.org/wiki/Q3430227
concepts[1].display_name	Vasomotor
concepts[2].id	https://openalex.org/C2778562196
concepts[2].level	2
concepts[2].score	0.7984622716903687
concepts[2].wikidata	https://www.wikidata.org/wiki/Q177708
concepts[2].display_name	Menopause
concepts[3].id	https://openalex.org/C198451711
concepts[3].level	2
concepts[3].score	0.5722400546073914
concepts[3].wikidata	https://www.wikidata.org/wiki/Q327657
concepts[3].display_name	Rheumatology
concepts[4].id	https://openalex.org/C126322002
concepts[4].level	1
concepts[4].score	0.4314002990722656
concepts[4].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[4].display_name	Internal medicine
concepts[5].id	https://openalex.org/C168563851
concepts[5].level	2
concepts[5].score	0.42613011598587036
concepts[5].wikidata	https://www.wikidata.org/wiki/Q1436668
concepts[5].display_name	Randomized controlled trial
concepts[6].id	https://openalex.org/C1862650
concepts[6].level	1
concepts[6].score	0.38733136653900146
concepts[6].wikidata	https://www.wikidata.org/wiki/Q186005
concepts[6].display_name	Physical therapy
concepts[7].id	https://openalex.org/C177713679
concepts[7].level	1
concepts[7].score	0.372108519077301
concepts[7].wikidata	https://www.wikidata.org/wiki/Q679690
concepts[7].display_name	Intensive care medicine
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.9363179206848145
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/vasomotor
keywords[1].score	0.8678548336029053
keywords[1].display_name	Vasomotor
keywords[2].id	https://openalex.org/keywords/menopause
keywords[2].score	0.7984622716903687
keywords[2].display_name	Menopause
keywords[3].id	https://openalex.org/keywords/rheumatology
keywords[3].score	0.5722400546073914
keywords[3].display_name	Rheumatology
keywords[4].id	https://openalex.org/keywords/internal-medicine
keywords[4].score	0.4314002990722656
keywords[4].display_name	Internal medicine
keywords[5].id	https://openalex.org/keywords/randomized-controlled-trial
keywords[5].score	0.42613011598587036
keywords[5].display_name	Randomized controlled trial
keywords[6].id	https://openalex.org/keywords/physical-therapy
keywords[6].score	0.38733136653900146
keywords[6].display_name	Physical therapy
keywords[7].id	https://openalex.org/keywords/intensive-care-medicine
keywords[7].score	0.372108519077301
keywords[7].display_name	Intensive care medicine
language	en
locations[0].id	doi:10.1007/s12325-025-03242-3
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S27230875
locations[0].source.issn	0741-238X, 1865-8652
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0741-238X
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Advances in Therapy
locations[0].source.host_organization	https://openalex.org/P4310320330
locations[0].source.host_organization_name	Adis, Springer Healthcare
locations[0].source.host_organization_lineage	https://openalex.org/P4310320330
locations[0].license	cc-by-nc
locations[0].pdf_url	https://link.springer.com/content/pdf/10.1007/s12325-025-03242-3.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Advances in Therapy
locations[0].landing_page_url	https://doi.org/10.1007/s12325-025-03242-3
locations[1].id	pmid:40465198
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	Advances in therapy
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/40465198
locations[2].id	pmh:oai:europepmc.org:11126308
locations[2].is_oa	True
locations[2].source.id	https://openalex.org/S4306400806
locations[2].source.issn
locations[2].source.type	repository
locations[2].source.is_oa	False
locations[2].source.issn_l
locations[2].source.is_core	False
locations[2].source.is_in_doaj	False
locations[2].source.display_name	Europe PMC (PubMed Central)
locations[2].source.host_organization	https://openalex.org/I1303153112
locations[2].source.host_organization_name	European Bioinformatics Institute
locations[2].source.host_organization_lineage	https://openalex.org/I1303153112
locations[2].license	other-oa
locations[2].pdf_url
locations[2].version	submittedVersion
locations[2].raw_type	Text
locations[2].license_id	https://openalex.org/licenses/other-oa
locations[2].is_accepted	False
locations[2].is_published	False
locations[2].raw_source_name
locations[2].landing_page_url	https://www.ncbi.nlm.nih.gov/pmc/articles/12313801
indexed_in	crossref, pubmed
authorships[0].author.id	https://openalex.org/A5078686392
authorships[0].author.orcid	https://orcid.org/0000-0002-7644-5298
authorships[0].author.display_name	Jonathan Douxfils
authorships[0].countries	BE, FR
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210128870
authorships[0].affiliations[0].raw_affiliation_string	Department of Biological Hematology, CHU Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France. [email protected].
authorships[0].affiliations[1].raw_affiliation_string	QUALIblood s.a., Namur, Belgium. [email protected].
authorships[0].affiliations[2].institution_ids	https://openalex.org/I149768937
authorships[0].affiliations[2].raw_affiliation_string	Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Rue de Bruxelles, 61, 5000, Namur, Belgium. [email protected].
authorships[0].institutions[0].id	https://openalex.org/I149768937
authorships[0].institutions[0].ror	https://ror.org/03d1maw17
authorships[0].institutions[0].type	education
authorships[0].institutions[0].lineage	https://openalex.org/I149768937
authorships[0].institutions[0].country_code	BE
authorships[0].institutions[0].display_name	University of Namur
authorships[0].institutions[1].id	https://openalex.org/I4210128870
authorships[0].institutions[1].ror	https://ror.org/02tcf7a68
authorships[0].institutions[1].type	healthcare
authorships[0].institutions[1].lineage	https://openalex.org/I4210128870
authorships[0].institutions[1].country_code	FR
authorships[0].institutions[1].display_name	Centre Hospitalier Universitaire de Clermont-Ferrand
authorships[0].author_position	first
authorships[0].raw_author_name	Jonathan Douxfils
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Department of Biological Hematology, CHU Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France. [email protected]., QUALIblood s.a., Namur, Belgium. [email protected]., Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Rue de Bruxelles, 61, 5000, Namur, Belgium. [email protected].
authorships[1].author.id	https://openalex.org/A5117835270
authorships[1].author.orcid
authorships[1].author.display_name	Emma Boretti
authorships[1].countries	BE
authorships[1].affiliations[0].institution_ids	https://openalex.org/I149768937
authorships[1].affiliations[0].raw_affiliation_string	Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Rue de Bruxelles, 61, 5000, Namur, Belgium.
authorships[1].institutions[0].id	https://openalex.org/I149768937
authorships[1].institutions[0].ror	https://ror.org/03d1maw17
authorships[1].institutions[0].type	education
authorships[1].institutions[0].lineage	https://openalex.org/I149768937
authorships[1].institutions[0].country_code	BE
authorships[1].institutions[0].display_name	University of Namur
authorships[1].author_position	middle
authorships[1].raw_author_name	Emma Boretti
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Rue de Bruxelles, 61, 5000, Namur, Belgium.
authorships[2].author.id	https://openalex.org/A5011109224
authorships[2].author.orcid	https://orcid.org/0000-0002-0827-5303
authorships[2].author.display_name	Charlotte Beaudart
authorships[2].countries	BE
authorships[2].affiliations[0].institution_ids	https://openalex.org/I149768937
authorships[2].affiliations[0].raw_affiliation_string	Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Rue de Bruxelles, 61, 5000, Namur, Belgium.
authorships[2].institutions[0].id	https://openalex.org/I149768937
authorships[2].institutions[0].ror	https://ror.org/03d1maw17
authorships[2].institutions[0].type	education
authorships[2].institutions[0].lineage	https://openalex.org/I149768937
authorships[2].institutions[0].country_code	BE
authorships[2].institutions[0].display_name	University of Namur
authorships[2].author_position	middle
authorships[2].raw_author_name	Charlotte Beaudart
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Rue de Bruxelles, 61, 5000, Namur, Belgium.
authorships[3].author.id	https://openalex.org/A5109403828
authorships[3].author.orcid
authorships[3].author.display_name	Jean-Michel Dogné
authorships[3].countries	BE
authorships[3].affiliations[0].institution_ids	https://openalex.org/I149768937
authorships[3].affiliations[0].raw_affiliation_string	Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Rue de Bruxelles, 61, 5000, Namur, Belgium.
authorships[3].institutions[0].id	https://openalex.org/I149768937
authorships[3].institutions[0].ror	https://ror.org/03d1maw17
authorships[3].institutions[0].type	education
authorships[3].institutions[0].lineage	https://openalex.org/I149768937
authorships[3].institutions[0].country_code	BE
authorships[3].institutions[0].display_name	University of Namur
authorships[3].author_position	last
authorships[3].raw_author_name	Jean-Michel Dogné
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Rue de Bruxelles, 61, 5000, Namur, Belgium.
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://link.springer.com/content/pdf/10.1007/s12325-025-03242-3.pdf
open_access.oa_status	hybrid
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Letter to the Editor Regarding: Safety of Fezolinetant for Treatment of Moderate-to-Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10756
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9991000294685364
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1311
primary_topic.subfield.display_name	Genetics
primary_topic.display_name	Estrogen and related hormone effects
related_works	https://openalex.org/W2030638344, https://openalex.org/W2802438622, https://openalex.org/W4380149603, https://openalex.org/W2090072464, https://openalex.org/W1966452808, https://openalex.org/W2527780442, https://openalex.org/W2969392348, https://openalex.org/W3036314380, https://openalex.org/W2418110596, https://openalex.org/W4321792046
cited_by_count	0
locations_count	3
best_oa_location.id	doi:10.1007/s12325-025-03242-3
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S27230875
best_oa_location.source.issn	0741-238X, 1865-8652
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	0741-238X
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Advances in Therapy
best_oa_location.source.host_organization	https://openalex.org/P4310320330
best_oa_location.source.host_organization_name	Adis, Springer Healthcare
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320330
best_oa_location.license	cc-by-nc
best_oa_location.pdf_url	https://link.springer.com/content/pdf/10.1007/s12325-025-03242-3.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Advances in Therapy
best_oa_location.landing_page_url	https://doi.org/10.1007/s12325-025-03242-3
primary_location.id	doi:10.1007/s12325-025-03242-3
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S27230875
primary_location.source.issn	0741-238X, 1865-8652
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0741-238X
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Advances in Therapy
primary_location.source.host_organization	https://openalex.org/P4310320330
primary_location.source.host_organization_name	Adis, Springer Healthcare
primary_location.source.host_organization_lineage	https://openalex.org/P4310320330
primary_location.license	cc-by-nc
primary_location.pdf_url	https://link.springer.com/content/pdf/10.1007/s12325-025-03242-3.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Advances in Therapy
primary_location.landing_page_url	https://doi.org/10.1007/s12325-025-03242-3
publication_date	2025-06-04
publication_year	2025
referenced_works	https://openalex.org/W4405894560, https://openalex.org/W4387749257, https://openalex.org/W4396946140, https://openalex.org/W2769063367, https://openalex.org/W2096691041, https://openalex.org/W3016864385, https://openalex.org/W2799931367, https://openalex.org/W1987952385
referenced_works_count	8
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	2
institutions_distinct_count	4
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.44999998807907104
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.23819208
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	True